KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Accumulated Expenses: 2013-2025

Historic Accumulated Expenses for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to $44.0 million.

  • CareDx's Accumulated Expenses fell 2.93% to $44.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.0 million, marking a year-over-year decrease of 2.93%. This contributed to the annual value of $43.4 million for FY2024, which is 4.71% down from last year.
  • CareDx's Accumulated Expenses amounted to $44.0 million in Q3 2025, which was down 0.12% from $44.0 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Accumulated Expenses ranged from a high of $50.2 million in Q2 2023 and a low of $23.6 million during Q1 2021.
  • Its 3-year average for Accumulated Expenses is $45.7 million, with a median of $45.5 million in 2023.
  • As far as peak fluctuations go, CareDx's Accumulated Expenses skyrocketed by 89.94% in 2022, and later dropped by 7.40% in 2023.
  • Quarterly analysis of 5 years shows CareDx's Accumulated Expenses stood at $37.9 million in 2021, then increased by 29.56% to $49.1 million in 2022, then fell by 7.40% to $45.5 million in 2023, then declined by 4.71% to $43.4 million in 2024, then decreased by 2.93% to $44.0 million in 2025.
  • Its Accumulated Expenses was $44.0 million in Q3 2025, compared to $44.0 million in Q2 2025 and $42.9 million in Q1 2025.